Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. (Q47418210)
Jump to navigation
Jump to search
scientific article published on 25 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. |
scientific article published on 25 November 2017 |
Statements
Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients (English)
Tomáš Jelínek
Vladimír Maisnar
Luděk Pour
Jiří Minařík
Evžen Gregora
Petr Kessler
Michal Sýkora
Hana Fraňková
Dagmar Adamová
Marek Wróbel
Peter Mikula
Jiří Jarkovský
Joris Diels
Xenia Gatopoulou
Šárka Veselá
Hervé Besson
15 February 2018